Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.08 USD | -1.00% | -2.91% | -9.29% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.